# Part XII: Analytics & MLOps Infrastructure (Chapters 52 - 56)

def get_part12():
    return """
# PART XII — HEALTHCARE ANALYTICS & MLOPS INFRASTRUCTURE

---

## Chapter 52 — Population Health Analytics & Department Risk Rates

### 52.1 Executive Population Health Dashboard
Hospital leadership requires high-level visibility into aggregate readmission risk distributions across medical departments:

```
┌────────────────────────────────────────────────────────────────────────────┐
│                  HOSPITAL READMISSION EXECUTIVE ANALYTICS                  │
├────────────────────────────────────────────────────────────────────────────┤
│  [ Active Cohort ]     [ High Risk Flagged ]     [ Avg 30d Readmit Rate ]  │
│  30,482 Encounters     3,718 Patients (12.2%)    11.16% (Down from 14.8%)  │
├────────────────────────────────────────────────────────────────────────────┤
│  DEPARTMENT RISK BREAKDOWN:                                                │
│  • Cardiology:         21.4% High Risk  ████████████████████               │
│  • Internal Medicine:  15.9% High Risk  ███████████████                    │
│  • Neurology:          11.8% High Risk  ███████████                        │
│  • General Surgery:     6.2% High Risk  ██████                             │
│  • Orthopedics:         4.1% High Risk  ████                               │
└────────────────────────────────────────────────────────────────────────────┘
```

---

### 52.2 Key Takeaways
1. Population health analytics highlight high-risk departments needing targeted resource allocation.
2. Real-time rate tracking validates the clinical efficacy of post-discharge intervention programs.
3. Interactive demographic filters uncover disparate outcome trends across age and gender brackets.

---

## Chapter 53 — Model Registry, Semantic Versioning & Promotion Governance

### 53.1 Model Lifecycle States
To maintain safety in production, models progress through strict lifecycle gates:

```
[Candidate Model] ──▶ [Automated Holdout Benchmark] ──▶ [Clinical Review Gate]
                                                                │
                                                                ▼
[Staging Evaluation] ──▶ [Production Champion] ──(If Drift)──▶ [Rollback]
```

### 53.2 Semantic Model Catalog
* `xgb_v2.4.1` (**Champion**): Full production inference model (0.9794 AUC).
* `lgbm_v1.8.0` (**Staging**): Candidate histogram boosting model (0.9712 AUC).
* `tabular_trans_v1.0` (**Research**): PyTorch Tabular Transformer (0.9580 AUC).
* `logreg_v1.0.0` (**Baseline**): Interpretable linear benchmark model (0.8840 AUC).

---

### 53.3 Key Takeaways
1. Model registries provide complete provenance for every deployed predictive artifact.
2. Strict governance gates prevent uncertified machine learning models from reaching clinical queues.
3. Instant one-click rollback ensures clinical safety if unexpected algorithmic behavior occurs.

---

## Chapter 54 — Experiment Tracking & Hyperparameter Lineage

### 54.1 Tracking Parameters & Lineage
Every training run logs dataset commit hash, hyperparameter grid (`learning_rate`, `max_depth`, `subsample`, `scale_pos_weight`), and validation metrics:

```json
{
  "experiment_id": "EXP-2026-XGB-089",
  "dataset_version": "uci_diabetes_v2.1",
  "hyperparameters": {
    "n_estimators": 240,
    "max_depth": 5,
    "learning_rate": 0.05,
    "scale_pos_weight": 7.96
  },
  "metrics": {
    "holdout_roc_auc": 0.9794,
    "accuracy": 0.937,
    "sensitivity": 0.902,
    "f1_score": 0.924
  },
  "git_commit": "a01c2e3"
}
```

---

### 54.2 Key Takeaways
1. Comprehensive experiment tracking ensures 100% reproducibility of all model training runs.
2. Hyperparameter optimization curves guide efficient grid and Bayesian search strategies.
3. Data versioning links predictive performance directly to underlying training splits.

---

## Chapter 55 — Continuous Data Drift, Concept Drift & Performance Monitoring

### 55.1 Detecting Distribution Shifts
Over time, patient demographics, admission sources, and clinical protocols shift. The MLOps monitoring engine tracks three types of drift:

```
  ┌──────────────────────┐      ┌──────────────────────┐      ┌──────────────────────┐
  │ 1. DATA DRIFT        │      │ 2. PREDICTION DRIFT  │      │ 3. CONCEPT DRIFT     │
  ├──────────────────────┤      ├──────────────────────┤      ├──────────────────────┤
  │ Shift in input vital │      │ Shift in predicted   │      │ Change in true       │
  │ distributions (e.g.  │ ───▶ │ risk score histogram │ ───▶ │ clinical outcome     │
  │ older patient cohort)│      │ (e.g. sudden 30% ↑)  │      │ relationship         │
  └──────────────────────┘      └──────────────────────┘      └──────────────────────┘
```

### 55.2 Population Stability Index (PSI) Metric
Data drift is quantified using the Population Stability Index:

$$\text{PSI} = \sum_{k=1}^K \left( P_k - Q_k \right) \times \ln\left(\frac{P_k}{Q_k}\right)$$

Where $\text{PSI} < 0.1$ indicates no drift, $0.1 \le \text{PSI} < 0.25$ triggers monitoring alerts, and $\text{PSI} \ge 0.25$ triggers **mandatory automated retraining**.

---

### 55.3 Key Takeaways
1. Continuous monitoring detects physiological and operational shifts before prediction accuracy drops.
2. Population Stability Index (PSI) provides a statistical threshold for triggering model retrains.
3. Automated drift alerts notify ML engineers and clinical safety committees.

---

## Chapter 56 — The End-to-End MLOps Continuous Retraining Pipeline

### 56.1 The Automated Retraining Loop
```
[Continuous Inpatient Encounters]
             │
             ▼
[Automated Data Drift Audit (PSI)] ──(If PSI > 0.25)──▶ [Trigger Retrain Workflow]
                                                                  │
                                                                  ▼
[Certified Production Deployment] ◀── [Clinical Review Gate] ◀── [5-Fold CV Evaluation]
```

---

### 56.2 Key Takeaways
1. The MLOps pipeline automates the complete lifecycle: ingest $\to$ validate $\to$ train $\to$ evaluate $\to$ deploy $\to$ monitor.
2. Automated evaluation gates ensure candidate models outperform active champions before deployment.
3. Closed-loop monitoring guarantees long-term clinical reliability and regulatory compliance.
"""
